1. Grobe W, Bieber T, Novak N. Pathophysiology of atopicdermatitis. J Dtsch Dermatol Ges. 2019;17(4):433- 40.
2. Weidinger S, Novak N. Atopic dermatitis. Lancet.2016;387(10023):1109-1122.
3. Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children:clinical features, pathophysiology, and treatment. ImmunolAllergy Clin North Am. 2015;35(1):161-183.
4. Theodosiou G, Montgomery S, Metsini A, Dalgard FJ,Svensson Å, Kobyletzki LB. Burden of atopic dermatitis inSwedish adults: a population-based study. Acta Derm Venereol.2019; 99(11): 964-970.
5. Flohr C, Mann J. New insights into the epidemiology ofchildhood atopic dermatitis. Allergy. 2014; 69(1): 3-16.
6. Bylund S, von Kobyletzki LB, Svalstedt M, Svensson Å. Prevalenceand incidence of atopic dermatitis: a systematic review. ActaDerm Venereol. 2020;100(12):320-9.
7. Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity andageing. Immunology. 2020;160(2):116-25.
8. Yang G, Seok JK, Kang HC, Cho Y-Y, Lee HS, Lee JY. Skin barrierabnormalities and immune dysfunction in atopic dermatitis. Int JMol Sci. 2020; 21(8):2867.
9. Leung DY, Berdyshev E, Goleva E. Cutaneous barrier dysfunctionin allergic diseases. J Allergy Clin Immunol. 2020;145(6):1485-97.
10. Boer M, Duchnik E, Maleszka R, Marchlewicz M. Structuraland biophysical characteristics of human skin in maintainingproper epidermal barrier function. Postepy Dermatol Alergol.2016;33(1):1-5.
11. Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin ExpAllergy. 2015;45(3):566-74.
12. Darlenski R, Fluhr JW. Influence of skin type, race, sex, andanatomic location on epidermal barrier function. Clin Dermatol.2012;30(3):269-73.
13. Potts RO, Buras Jr EM, Chrisman Jr DA. Changes with age in themoisture content of human skin. J Invest Dermatol. 1984;82(1):97-100.
14. Sator P-G, Schmidt JB, Hönigsmann H. Comparison ofepidermal hydration and skin surface lipids in healthy individualsand in patients with atopic dermatitis. J Am Acad Dermatol.2003;48(3):352-8.
15. Güneş H, Nazik H, Özkars MY, et al. The assessment of skinsebum and moisture content of infants with atopic dermatitis.Turk J Med Sci. 2020;50(4):844-8.
16. Krysiak ZJ, Stachewicz U. Electrospun fibers as carriers fortopical drug delivery and release in skin bandages and patchesfor atopic dermatitis treatment. Wiley Interdiscip Rev NanomedNanobiotechnol. 2023;15(1):e1829.
17. Nygaard U, Deleuran M, Vestergaard C. Emerging treatmentoptions in atopic dermatitis: topical therapies. Dermatology.2018;233(5):333-43.
18. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van derSpek FB. Practical issues on interpretation of scoring atopicdermatitis: the SCORAD index, objective SCORAD and thethree-item severity score. Br J Dermatol. 2007;157(4):645-648.
19. Stalder JF, Taïeb A, Atherton DJ, et al. Severity scoring of atopicdermatitis: The SCORAD index: Consensus report of theeuropean task force on atopic dermatitis. Dermatology. 1993;186(1): 23-31.
20. Chovatiya R, Silverberg JI. Pathophysiology of atopic dermatitisand psoriasis: implications for management in children. Children.2019;6(10):108.
21. Frantz T, Wright EG, Balogh EA, Cline A, Adler-Neal AL,Feldman SR. Topical and oral therapies for childhood atopicdermatitis and plaque psoriasis. Children. 2019;6(11):125.
22. Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, anddermatologic quality of life in adolescents with atopic dermatitis.J Allergy Clin Immunol. 2011; 128(3):668-671.
23. Egawa M, Koizumi K, Hirao T. Changes in facial moisturedistribution and feelings of moisture/dryness among variousenvironmental temperatures and humidities in summer andwinter. Skin Res Technol. 2020;26(6):937-48.
24. Bumbacea RS, Corcea SL, Ali S, Dinica LC, Fanfaret IS, Boda D.Mite allergy and atopic dermatitis: Is there a clear link? Exp TherMed. 2020;20(4):3554-60.
25. Evangelista MTP, Abad-Casintahan F, Lopez-Villafuerte L.The effect of topical virgin coconut oil on SCORAD index,transepidermal water loss, and skin capacitance in mild tomoderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100-8.
26. Brunner PM, Khattri S, Garcet S, et al. A mild topical steroidleads to progressive anti-inflammatory effects in the skin ofpatients with moderate-to-severe atopic dermatitis. J Allergy ClinImmunol. 2016;138(1):169-178.
27. Lyakhovitsky A, Barzilai A, Heyman R, et al. Low-dosemethotrexate treatment for moderate-to-severe atopic dermatitisin adults. J Eur Acad Dermatol Venereol. 2010;24(1):43-49.
28. Kim BE, Leung DY. Significance of skin barrier dysfunction inatopic dermatitis. Allergy Asthma Immunol Res. 2018;10(3):207-15.
29. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care forthe management of atopic dermatitis: Section 2. Managementand treatment of atopic dermatitis with topical therapies. J AmAcad Dermatol. 2014;71(1): 116-132.
30. Atherton DJ. Topical corticosteroids in atopic dermatitis. BMJ.2003;327(7421):942-3.
31. Kempers S, Boguniewicz M, Carter E, et al. A randomizedinvestigator-blinded study comparing pimecrolimus cream 1%with tacrolimus ointment 0.03% in the treatment of pediatricpatients with moderate atopic dermatitis. J Am Acad Dermatol.2004;51:515-525.
32. Hultsch T, Kapp A, Spergel J. Immunomodulation and safetyof topical calcineurin inhibitors for the treatment of atopicdermatitis. Dermatology. 2005;211(2):174-87.